Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-26

Clinical Trial Update: Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing fractional Erbium laser-assisted 5-fluorouracil versus laser-assisted corticosteroid for treatment of keloid scars has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-fluorouracil (topical/injected formulation used with Erbium laser) (5-fluorouracil)
  • Corticosteroid (laser-assisted) (corticosteroid)

Snippet

Sponsor: NYU Langone Health | Conditions: Keloid Scar | Phase 4 | Status: COMPLETED | Results posted: 2024-03-26